Research Article
PDE5 Overexpression in Well-Differentiated Thyroid Carcinomas Is Associated with Lymph Node Metastasis
Table 2
Correlation between PDE5 expression and clinicopathological features.
| Clinicopathological parameters | | Total | The level of PDE5 expression | value | | High (%) | Low (%) |
| Gender | Male | 36 | 19 (36.5) | 17 (33.3) | 0.733 | Female | 67 | 33 (63.5) | 34 (66.7) | Age (years) | <45 | 67 | 39 (75.0) | 28 (54.9) | 0.032 | ≥45 | 36 | 13 (25.0) | 23 (45.1) | Histological type | PTC | 100 | 51 (98.1) | 49 (96.1) | 0.618 | FTC | 3 | 1 (1.9) | 2 (3.9) | Focus | Single | 58 | 30 (57.7) | 28 (54.9) | 0.774 | Multiple | 43 | 21 (42.3) | 22 (45.1) | Invasion of capsule or ETE | No | 89 | 45 (86.5) | 44 (86.3) | 0.969 | Yes | 14 | 7 (13.5) | 7 (13.7) | Distant metastasis | M0 | 84 | 47 (90.4) | 37 (72.5) | 0.020 | M1 | 19 | 5 (9.6) | 14 (27.5) | LN involvement | N0 | 46 | 16 (30.8) | 30 (58.8) | 0.004 | N1 | 57 | 36 (69.2) | 21 (41.2) | OR = 2.79 |
|
|
ETE: extracapsular extension; PTC: papillary thyroid cancer; FTC: follicular thyroid cancer.
|